Press release
Orphan Drugs Market By End-user, Type And Geography - Forecast And Analysis To 2032 | Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Amgen, Biogen
Orphan Drugs Market
As per the orphan drugs market report by The Business Research Company, the rising prevalence of rare diseases will continue to be a driver of the orphan drugs market. Any disease that affects a small percentage of the population is rare. Rare disease treatments often require a cold chain, a supply chain regulated by the temperature that is not readily accessible in all countries. Orphan diseases or rare diseases occur rarely among people (i.e. 7 out of 10,000). However, globally, the prevalence of rare diseases is increasing in recent years. The elderly population is increasing rapidly across the world, and it is expected to continue over the forecast period. By 2030, the population aged 65 year and above is expected to reach approximately 70 million in the USA.
The global orphan drugs market grew from $154.81 billion in 2022 to $170.77 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orphan drugs market is expected to grow from $293.6 billion in 2027 at a CAGR of 14.5%.
Read More On The Orphan Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report
Major competitors in the Orphan Drugs market include Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Amgen, Biogen, Bayer, Novartis AG.
The Orphan Drugs market is segmented -
• By Therapy Area: Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory.
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales.
• By Drug Type: Biological, Non-Biological.
• By Disease Type: Oncology, Haematology, Neurology, Cardiovascular, Other Disease Types.
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Orphan Drugs market.
Request A Free Sample Of The Orphan Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2823&type=smp
Orphan drugs refer to drugs that are specifically designed to treat an uncommon medical problem. It might be characterised as medicines that address public health needs but are not produced by the pharmaceutical industry due to financial constraints. Since a chemical may be used to treat a common condition but not have been designed for another, more rare indication, the indications of a medicine may likewise be called "orphan."
The Table Of Content For The Orphan Drugs Market Include:
1. Executive Summary
2. Orphan Drugs Market Characteristics
3. Orphan Drugs Market Trends And Strategies
4. Orphan Drugs Market - Macro Economic Scenario
5. Orphan Drugs Market Size And Growth
……
26. Africa Orphan Drugs Market
27. Orphan Drugs Market Competitive Landscape And Company Profiles
28. Orphan Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Orphan Drugs Market
30. Orphan Drugs Market Future Outlook and Potential Analysis
The "Global Orphan Drugs Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market By End-user, Type And Geography - Forecast And Analysis To 2032 | Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Amgen, Biogen here
News-ID: 2875085 • Views: …
More Releases from The Business research company
Customized Premixes Market Share, Opportunities Analysis, Recent Trends, Regiona …
The customized premixes market size has grown strongly in recent years. It will grow from $1.86 billion in 2023 to $2.01 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increase in health awareness, change in dietary patterns, rise in disposable income, aging population, rise in nutrition deficiencies.
The customized premixes market…
Custom T-Shirt Printing Market Size, Regional Overview, Competitive Landscape, B …
The custom t-shirt printing market size has grown rapidly in recent years. It will grow from $7.46 billion in 2023 to $8.22 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to customization and personalization trend
growth of e-commerce and online printing platforms, increased promotional and marketing activities, increased apparel and fashion industry collaboration, cultural and social…
Cryogenic Pump Market Size, Share , Latest Trends, Key Players And Forecast To 2 …
The cryogenic pump market size has grown strongly in recent years. It will grow from $2.27 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in industrial gas applications (e.g., lng, lpg, liquid nitrogen), expansion of the healthcare and medical gases market, increased demand for cryogenic equipment…
Cryogenic Equipment Market Growth Statistics, Regional Analysis, Top Players, Si …
The cryogenic equipment market size has grown strongly in recent years. It will grow from $14.44 billion in 2023 to $15.85 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased industrial gas demand, increased need for energy storage and distribution, healthcare and medical applications, space exploration, and energy efficiency.
The cryogenic equipment market size is…
More Releases for Orphan
Potential Opportunities of Orphan Drugs Market
As per Fortune Business Insights, the North America Orphan Drugs Market was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan…
Orphan Drug Pipeline & Regulatory Insight 2025
Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights:
Global Orphan Drug Market Overview: US$ 260 Billion Opportunity
Global Orphan Drug market by Segment
Regulatory Landscape: USA, Europe & Asia
Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia
Global Orphan Drug Clinical Pipeline Insight: 973 Drugs
Marketed Orphan Drug Clinical Insight: 366 Drugs
The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
